Skip to main content
Top
Published in: Drugs & Aging 1/2012

01-01-2012 | Review Article

Psychotropic Drug-Induced Falls in Older People

A Review of Interventions Aimed at Reducing the Problem

Authors: Professor Keith D. Hill, Rohan Wee

Published in: Drugs & Aging | Issue 1/2012

Login to get access

Abstract

Falls are a common health problem for older people, and psychotropic medications have been identified as an important independent fall risk factor. The objective of this paper was to review the literature relating to the effect of psychotropic medications on falls in older people, with a particular focus on evidence supporting minimization of their use to reduce risk of falls. A literature search identified 18 randomized trials meeting the inclusion criteria for the review of effectiveness of psychotropic medication withdrawal studies, including four with falls outcomes. One of these, which targeted reduced psychotropic medication use in the community, reported a 66% reduction in falls, while the other studies demonstrated some success in reducing psychotropic medication use but with mixed effects on falls. Other randomized trials evaluated various approaches to reducing psychotropic medications generally or specific classes of psychotropic medications (e.g. benzodiazepines), but did not report fall-related outcomes. Overall, these studies reported moderate success in reducing psychotropic medication use, and a number reported no or limited worsening of key outcomes such as sleep quality or behavioural difficulties associated with withdrawal of psychotropic medication use. Reduced prescription of psychotropic medications (e.g. seeking non-pharmacological alternatives to their use in place of prescription in the first place or, for those patients for whom these medications are deemed necessary, regular monitoring and efforts to cease use or wean off use over time) needs to be a strong focus in clinical practice for three reasons. Firstly, psychotropic medications are commonly prescribed for older people, both in the community and especially in the residential care setting, and their effectiveness in a number of clinical groups has been questioned. Secondly, there is strong evidence of an association between substantially increased risk of falls and use of a number of psychotropic medications, including benzodiazepines (particularly, the long-acting agents), antidepressants and antipsychotic drugs. Finally, the largest effect of any randomized trial of falls prevention to date was achieved with a single intervention consisting of weaning psychotropic drug users off their medications.
Literature
1.
go back to reference Lord S, Ward J, Williams P, et al. An epidemiological study of falls in older community-dwelling women: the Randwick falls and fractures study. Aust J Public Health 1993; 17:240–5PubMed Lord S, Ward J, Williams P, et al. An epidemiological study of falls in older community-dwelling women: the Randwick falls and fractures study. Aust J Public Health 1993; 17:240–5PubMed
2.
go back to reference Kannus P, Parkkari J, Sievanen H, et al. Epidemiology of hip fractures. Bone 1996 Jan; 18(1 Suppl.): 57S–63SPubMed Kannus P, Parkkari J, Sievanen H, et al. Epidemiology of hip fractures. Bone 1996 Jan; 18(1 Suppl.): 57S–63SPubMed
3.
go back to reference O’Loughlin JL, Robitaille Y, Boivin JF, et al. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993 Feb 1; 137(3): 342–54PubMed O’Loughlin JL, Robitaille Y, Boivin JF, et al. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993 Feb 1; 137(3): 342–54PubMed
4.
go back to reference Todd C, Skelton D. What are the main risk factors for falls among older people and what are the most effective interventions to prevent these falls? Copenhagen: World Health Organisation Regional Office for Europe (Health Evidence Network report), 2004 Todd C, Skelton D. What are the main risk factors for falls among older people and what are the most effective interventions to prevent these falls? Copenhagen: World Health Organisation Regional Office for Europe (Health Evidence Network report), 2004
5.
go back to reference Campbell A, Reinken J, Allan B, et al. Falls in old age: a study of frequency and related clinical factors. Age Ageing 1981; 10(4): 264–70PubMed Campbell A, Reinken J, Allan B, et al. Falls in old age: a study of frequency and related clinical factors. Age Ageing 1981; 10(4): 264–70PubMed
6.
go back to reference Cassell E, Clapperton A. Preventing injury in Victorian seniors aged 65 years and older. Melbourne: Monash University Accident Research Centre, Victorian Injury Surveillance Unit (VISU), 2008 Cassell E, Clapperton A. Preventing injury in Victorian seniors aged 65 years and older. Melbourne: Monash University Accident Research Centre, Victorian Injury Surveillance Unit (VISU), 2008
7.
go back to reference Cameron I, Murray G, Gillespie L, et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010 Jan 20; (1): CD005465 Cameron I, Murray G, Gillespie L, et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010 Jan 20; (1): CD005465
8.
go back to reference Gillespie L, Robertson M, Gillespie W, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009 Apr 15; (2): CD007146 Gillespie L, Robertson M, Gillespie W, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009 Apr 15; (2): CD007146
9.
go back to reference Kreisfeld R, Harrison J. Hospital separations due to injury and poisoning 2005–06. Canberra (ACT): Australian Institute of Health and Welfare (AIHW), 2010 Kreisfeld R, Harrison J. Hospital separations due to injury and poisoning 2005–06. Canberra (ACT): Australian Institute of Health and Welfare (AIHW), 2010
10.
go back to reference Kannus P, Niemi S, Parkkari J, et al. Epidemiology of adulthood injuries: a quickly changing injury profile in Finland. J Clin Epidemiol 2001; 54: 597–602PubMed Kannus P, Niemi S, Parkkari J, et al. Epidemiology of adulthood injuries: a quickly changing injury profile in Finland. J Clin Epidemiol 2001; 54: 597–602PubMed
11.
go back to reference Moller J. Projected costs of falls related injury to older persons due to demographic change in Australia. Report to the Commonwealth Department of Health and Ageing, under the National Falls Prevention for Older People Initiative. Canberra (ACT): Department of Communications, Information Technology and the Arts, Commonwealth of Australia, 2003 Moller J. Projected costs of falls related injury to older persons due to demographic change in Australia. Report to the Commonwealth Department of Health and Ageing, under the National Falls Prevention for Older People Initiative. Canberra (ACT): Department of Communications, Information Technology and the Arts, Commonwealth of Australia, 2003
12.
go back to reference White SM, Griffiths R. Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 2011 Nov;42(11): 1230–3PubMed White SM, Griffiths R. Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 2011 Nov;42(11): 1230–3PubMed
13.
go back to reference Kannus P, Niemi S, Parkkari J, et al. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999; 353(9155): 802–5PubMed Kannus P, Niemi S, Parkkari J, et al. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999; 353(9155): 802–5PubMed
14.
go back to reference Wilson RT, Chase GA, Chrischilles EA, et al. Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. Am J Public Health 2006 Jul; 96(7): 1210–8PubMedCentralPubMed Wilson RT, Chase GA, Chrischilles EA, et al. Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. Am J Public Health 2006 Jul; 96(7): 1210–8PubMedCentralPubMed
15.
go back to reference Bentler SE, Liu L, Obrizan M, et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 2009 Nov 15; 170(10): 1290–9PubMedCentralPubMed Bentler SE, Liu L, Obrizan M, et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 2009 Nov 15; 170(10): 1290–9PubMedCentralPubMed
16.
go back to reference Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 2000 Sep; 55(9): M498–507PubMed Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 2000 Sep; 55(9): M498–507PubMed
17.
go back to reference Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep 2003; 1(2): 78–85PubMed Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep 2003; 1(2): 78–85PubMed
18.
go back to reference Scheffer AC, Schuurmans MJ, van Dijk N, et al. Fear of falling: measurement strategy, prevalence, risk factors and consequences among older persons. Age Ageing 2008 Jan; 37(1): 19–24PubMed Scheffer AC, Schuurmans MJ, van Dijk N, et al. Fear of falling: measurement strategy, prevalence, risk factors and consequences among older persons. Age Ageing 2008 Jan; 37(1): 19–24PubMed
19.
go back to reference Murphy SL, Williams CS, Gill TM. Characteristics associated with fear of falling and activity restriction in community-living older persons. J Am Geriatr Soc 2002 Mar; 50(3): 516–20PubMedCentralPubMed Murphy SL, Williams CS, Gill TM. Characteristics associated with fear of falling and activity restriction in community-living older persons. J Am Geriatr Soc 2002 Mar; 50(3): 516–20PubMedCentralPubMed
20.
go back to reference Lord S, Sherrington C, Menz H, et al. Falls in older people: risk factors and strategies for prevention. 2nd ed. Cambridge: Cambridge University Press, 2007 Lord S, Sherrington C, Menz H, et al. Falls in older people: risk factors and strategies for prevention. 2nd ed. Cambridge: Cambridge University Press, 2007
21.
go back to reference Bloch F, Thibaud M, Dugué B, et al. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health 2011; 23(2): 329–46PubMed Bloch F, Thibaud M, Dugué B, et al. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health 2011; 23(2): 329–46PubMed
22.
go back to reference Preville M, Hebert R, Boyer R, et al. Correlates of psychotropic drug use in the elderly compared to adults aged 18–64: results from the Quebec Health Survey. Aging Ment Health 2001 Aug; 5(3): 216–24PubMed Preville M, Hebert R, Boyer R, et al. Correlates of psychotropic drug use in the elderly compared to adults aged 18–64: results from the Quebec Health Survey. Aging Ment Health 2001 Aug; 5(3): 216–24PubMed
23.
go back to reference Mann E, Kopke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr 2009 May 21; 9: 18PubMedCentralPubMed Mann E, Kopke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr 2009 May 21; 9: 18PubMedCentralPubMed
24.
go back to reference Gobert M, D’Hoore W. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 2005 Aug; 20(8): 712–21PubMed Gobert M, D’Hoore W. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 2005 Aug; 20(8): 712–21PubMed
25.
go back to reference Hilmer S, Mager D, Simonsick E, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167(8): 781–7PubMed Hilmer S, Mager D, Simonsick E, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167(8): 781–7PubMed
26.
go back to reference Psychotropic Expert Group. Therapeutic guidelines: psychotropic. Version 6. Melbourne (VIC): Therapeutic Guidelines Limited, 2008 Psychotropic Expert Group. Therapeutic guidelines: psychotropic. Version 6. Melbourne (VIC): Therapeutic Guidelines Limited, 2008
27.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision (DSMIV-TR). Arlington (VA): American Psychiatric Association, 2000 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision (DSMIV-TR). Arlington (VA): American Psychiatric Association, 2000
28.
go back to reference Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med 2009 Dec 14; 169(22): 2128–39PubMed Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med 2009 Dec 14; 169(22): 2128–39PubMed
29.
go back to reference Jorm AF, Grayson D, Creasey H, et al. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 2000 Feb; 24(1): 7–10PubMed Jorm AF, Grayson D, Creasey H, et al. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 2000 Feb; 24(1): 7–10PubMed
30.
go back to reference Voyer P, Preville M, Cohen D, et al. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can 2010; 29(2): 205–13 Voyer P, Preville M, Cohen D, et al. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can 2010; 29(2): 205–13
31.
go back to reference Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging 2006; 23(4): 271–87PubMed Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging 2006; 23(4): 271–87PubMed
32.
go back to reference Petrovic M, Mariman A, Warie H, et al. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 2003 Jan–Feb; 58(1): 27–36PubMed Petrovic M, Mariman A, Warie H, et al. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 2003 Jan–Feb; 58(1): 27–36PubMed
33.
go back to reference Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med 2010 Nov; 26(4): 583–605PubMed Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med 2010 Nov; 26(4): 583–605PubMed
34.
go back to reference Johnsen E, Jørgensen HA. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry 2008; 8: 31PubMedCentralPubMed Johnsen E, Jørgensen HA. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry 2008; 8: 31PubMedCentralPubMed
35.
go back to reference Tandon R. Safety and tolerability: how do newer generation “atypical” antipsychotics compare? Psychiatr Q 2002; 73(4): 297–311PubMed Tandon R. Safety and tolerability: how do newer generation “atypical” antipsychotics compare? Psychiatr Q 2002; 73(4): 297–311PubMed
36.
go back to reference Landi F, Onder G, Cesari M, et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005 May; 60(5): 622–6PubMed Landi F, Onder G, Cesari M, et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005 May; 60(5): 622–6PubMed
37.
go back to reference Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998; 44(4): 217–21PubMed Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998; 44(4): 217–21PubMed
38.
go back to reference Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009 Nov 23; 169(21): 1952–60PubMed Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009 Nov 23; 169(21): 1952–60PubMed
39.
go back to reference Deandrea S, Lucenteforte E, Bravi F, et al. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 2010; 21(5): 658–68PubMed Deandrea S, Lucenteforte E, Bravi F, et al. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 2010; 21(5): 658–68PubMed
40.
go back to reference Vestergaard P. Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics. Cur Drug Saf 2008; 3(3): 185–9 Vestergaard P. Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics. Cur Drug Saf 2008; 3(3): 185–9
41.
go back to reference Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007 Jan 22; 167(2): 188–94PubMed Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007 Jan 22; 167(2): 188–94PubMed
42.
go back to reference Cumming R, Le Couteur D. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17(11): 825–37PubMed Cumming R, Le Couteur D. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17(11): 825–37PubMed
43.
go back to reference van der Hooft C, Schoofs M, Ziere G, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 2008; 66(2): 276–82PubMedCentralPubMed van der Hooft C, Schoofs M, Ziere G, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 2008; 66(2): 276–82PubMedCentralPubMed
44.
go back to reference Ginzburg R, Rosero E. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 2009; 43(1): 98–103PubMed Ginzburg R, Rosero E. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 2009; 43(1): 98–103PubMed
45.
go back to reference Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging 2008; 25(6): 501–19PubMed Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging 2008; 25(6): 501–19PubMed
46.
go back to reference Wang P, Bohn R, Glynn R, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158(6): 892–8PubMed Wang P, Bohn R, Glynn R, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158(6): 892–8PubMed
47.
go back to reference Wu Q, Liu J, Gallegos-Orozco J, et al. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 2010; 21(10): 1627–35PubMed Wu Q, Liu J, Gallegos-Orozco J, et al. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 2010; 21(10): 1627–35PubMed
48.
go back to reference Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25(1): 61–70PubMed Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25(1): 61–70PubMed
49.
go back to reference Panneman MJ, Goettsch WG, Kramarz P, et al. The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study. Drugs Aging 2003; 20(11): 833–9PubMed Panneman MJ, Goettsch WG, Kramarz P, et al. The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study. Drugs Aging 2003; 20(11): 833–9PubMed
50.
go back to reference Kerse N, Flicker L, Pfaff JJ, et al. Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS One 2008; 3(6): e2423PubMedCentralPubMed Kerse N, Flicker L, Pfaff JJ, et al. Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS One 2008; 3(6): e2423PubMedCentralPubMed
51.
go back to reference Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007 Jun 25; 167(12): 1240–5PubMed Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007 Jun 25; 167(12): 1240–5PubMed
52.
go back to reference Rossi S, editor. Australian medicines handbook 2011. 11th ed. Adelaide (SA): Australian Medicines Handbook Pty. Limited, 2011 Rossi S, editor. Australian medicines handbook 2011. 11th ed. Adelaide (SA): Australian Medicines Handbook Pty. Limited, 2011
53.
go back to reference Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002 Oct; 50(10): 1629–37PubMed Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002 Oct; 50(10): 1629–37PubMed
54.
go back to reference Petty SJ, Hill KD, Haber NE, et al. Balance impairment in chronic antiepileptic drug users: a twin and sibling study. Epilepsia 2009; 51(2): 280–8PubMed Petty SJ, Hill KD, Haber NE, et al. Balance impairment in chronic antiepileptic drug users: a twin and sibling study. Epilepsia 2009; 51(2): 280–8PubMed
55.
go back to reference Leipzig R, Cumming R, Tinetti M. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–9PubMed Leipzig R, Cumming R, Tinetti M. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–9PubMed
56.
go back to reference Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls: a prospective study in a large community-dwelling elderly cohort. BMC Geriatr 2009 Jul 23; 9: 30PubMedCentralPubMed Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls: a prospective study in a large community-dwelling elderly cohort. BMC Geriatr 2009 Jul 23; 9: 30PubMedCentralPubMed
57.
go back to reference Lord SR, Anstey KJ, Williams P, et al. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol 1995 Mar; 39(3): 227–34PubMedCentralPubMed Lord SR, Anstey KJ, Williams P, et al. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol 1995 Mar; 39(3): 227–34PubMedCentralPubMed
58.
go back to reference Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000 Jun; 48(6): 682–5PubMed Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000 Jun; 48(6): 682–5PubMed
59.
go back to reference Golden AG, Ma Q, Nair V, et al. Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database. Ann Pharmacother 2010; 44(9): 1369–75PubMed Golden AG, Ma Q, Nair V, et al. Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database. Ann Pharmacother 2010; 44(9): 1369–75PubMed
60.
go back to reference Passaro A, Volpato S, Romagnoni F, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol 2000 Dec; 53(12): 1222–9PubMed Passaro A, Volpato S, Romagnoni F, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol 2000 Dec; 53(12): 1222–9PubMed
61.
go back to reference Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf 2002 Dec; 11(8): 663–9PubMed Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf 2002 Dec; 11(8): 663–9PubMed
62.
go back to reference Horikawa E, Matsui T, Arai H, et al. Risk of falls in Alzheimer’s disease: a prospective study. Intern Med 2005 Jul; 44(7): 717–21PubMed Horikawa E, Matsui T, Arai H, et al. Risk of falls in Alzheimer’s disease: a prospective study. Intern Med 2005 Jul; 44(7): 717–21PubMed
63.
go back to reference Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010; 75(14): 1263–9PubMedCentralPubMed Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010; 75(14): 1263–9PubMedCentralPubMed
64.
go back to reference Mehta S, Chen H, Johnson ML, et al. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs 2010; 27(10): 815–29 Mehta S, Chen H, Johnson ML, et al. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs 2010; 27(10): 815–29
65.
go back to reference Kallin K, Gustafson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res 2004 Aug; 16(4): 270–6PubMed Kallin K, Gustafson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res 2004 Aug; 16(4): 270–6PubMed
66.
go back to reference Ballard C, Cream J. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument. Int Psychogeriatr 2005 Mar; 17(1): 4–12; discussion 22-9PubMed Ballard C, Cream J. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument. Int Psychogeriatr 2005 Mar; 17(1): 4–12; discussion 22-9PubMed
67.
go back to reference Campbell A, Robertson M, Gardner M, et al. Psychotropic medication withdrawal and a home based exercise program to prevent falls: a randomised controlled trial. J Am Geriatr Soc 1999; 47(7): 850–3PubMed Campbell A, Robertson M, Gardner M, et al. Psychotropic medication withdrawal and a home based exercise program to prevent falls: a randomised controlled trial. J Am Geriatr Soc 1999; 47(7): 850–3PubMed
68.
go back to reference Patterson S, Hughes C, Crealey G, et al. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study). J Am Geriatr Soc 2010; 58: 44–53PubMed Patterson S, Hughes C, Crealey G, et al. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study). J Am Geriatr Soc 2010; 58: 44–53PubMed
69.
go back to reference Weber V, White A, McIlvried R. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med 2008 Apr; 23(4): 399–404PubMedCentralPubMed Weber V, White A, McIlvried R. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med 2008 Apr; 23(4): 399–404PubMedCentralPubMed
70.
go back to reference Pit SW, Byles JE, Henry DA, et al. A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust 2007 Jul 2; 187(1): 23–30PubMed Pit SW, Byles JE, Henry DA, et al. A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust 2007 Jul 2; 187(1): 23–30PubMed
71.
go back to reference Midlöv P, Bondesson A, Eriksson T, et al. Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden. Fam Pract 2006; 23(1): 60–4PubMed Midlöv P, Bondesson A, Eriksson T, et al. Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden. Fam Pract 2006; 23(1): 60–4PubMed
72.
go back to reference Findlay D, Sharma J, McEwen J, et al. Double-blind controlled withdrawal of thioridazine treatment in elderly female inpatients with senile dementia. Int J Geriatr Psychiatry 1989; 4: 115–20 Findlay D, Sharma J, McEwen J, et al. Double-blind controlled withdrawal of thioridazine treatment in elderly female inpatients with senile dementia. Int J Geriatr Psychiatry 1989; 4: 115–20
73.
go back to reference Cohen-Mansfield J, Lipson S, Werner P, et al. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch Intern Med 1999; 159(15): 1733–40PubMed Cohen-Mansfield J, Lipson S, Werner P, et al. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch Intern Med 1999; 159(15): 1733–40PubMed
74.
go back to reference Ruths S, Straand J, Nygaard H, et al. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J Am Geriatr Soc 2004; 52(10): 1737–43PubMed Ruths S, Straand J, Nygaard H, et al. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J Am Geriatr Soc 2004; 52(10): 1737–43PubMed
75.
go back to reference van Reekum R, Clarke D, Conn D, et al. A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. Int Psychogeriatr 2002; 14(2): 197–210PubMed van Reekum R, Clarke D, Conn D, et al. A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. Int Psychogeriatr 2002; 14(2): 197–210PubMed
76.
go back to reference Ten Wolde G, Dijkstra A, van Empelen P, et al. Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial. Addiction 2008; 103(4): 662–70PubMed Ten Wolde G, Dijkstra A, van Empelen P, et al. Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial. Addiction 2008; 103(4): 662–70PubMed
77.
go back to reference Habraken H, Soenen K, Blondeel L, et al. Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research. Eur J Clin Pharmacol 1997; 51(5): 355–8PubMed Habraken H, Soenen K, Blondeel L, et al. Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research. Eur J Clin Pharmacol 1997; 51(5): 355–8PubMed
78.
go back to reference van Eijk M, Avorn J, Porsius A, et al. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 2001; 322(7287): 654–7PubMedCentralPubMed van Eijk M, Avorn J, Porsius A, et al. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 2001; 322(7287): 654–7PubMedCentralPubMed
79.
go back to reference Ulfvarson J, Adami J, Wredling R, et al. Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression. Eur J Clin Pharmacol 2003; 59(10): 735–40PubMed Ulfvarson J, Adami J, Wredling R, et al. Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression. Eur J Clin Pharmacol 2003; 59(10): 735–40PubMed
80.
go back to reference Minett T, Thomas A, Wilkinson L, et al. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 2003; 18(11): 988–93PubMed Minett T, Thomas A, Wilkinson L, et al. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 2003; 18(11): 988–93PubMed
81.
go back to reference Ballard C, Hanney ML, Theodoulou M, et al. The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009 Feb; 8(2): 151–7PubMed Ballard C, Hanney ML, Theodoulou M, et al. The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009 Feb; 8(2): 151–7PubMed
82.
go back to reference Rikala M, Korhonen M, Sulkava R, et al. The effects of medication assessment on psychotropic drug use in the community-dwelling elderly. Int Psychogeriatr 2011; 23(3): 473–84PubMed Rikala M, Korhonen M, Sulkava R, et al. The effects of medication assessment on psychotropic drug use in the community-dwelling elderly. Int Psychogeriatr 2011; 23(3): 473–84PubMed
83.
go back to reference Hill A, Hoffmann T, Hill K, et al. Measuring falls events in acute hospitals-a comparison of three reporting methods to identify missing data in the hospital reporting system. J Am Geriatr Soc 2010; 58(7): 1347–52PubMed Hill A, Hoffmann T, Hill K, et al. Measuring falls events in acute hospitals-a comparison of three reporting methods to identify missing data in the hospital reporting system. J Am Geriatr Soc 2010; 58(7): 1347–52PubMed
84.
go back to reference Lamb S, Jørstad-Stein E, Hauer K, et al., Prevention of Falls Network Europe and Outcomes Consensus Group. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005; 53(9): 1618–22PubMed Lamb S, Jørstad-Stein E, Hauer K, et al., Prevention of Falls Network Europe and Outcomes Consensus Group. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005; 53(9): 1618–22PubMed
85.
go back to reference Meredith S, Feldman P, Frey D, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc 2002; 50(9): 1484–91PubMed Meredith S, Feldman P, Frey D, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc 2002; 50(9): 1484–91PubMed
86.
go back to reference Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006 Nov; 35(6): 586–91PubMed Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006 Nov; 35(6): 586–91PubMed
87.
go back to reference Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2(4): 257–64PubMed Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2(4): 257–64PubMed
88.
go back to reference Nishtala P, McLachlan A, Bell J, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16(8): 621–32PubMed Nishtala P, McLachlan A, Bell J, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16(8): 621–32PubMed
89.
go back to reference Oude Voshaar R, Gorgels W, Mol A, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry 2003; 182: 498–504 Oude Voshaar R, Gorgels W, Mol A, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry 2003; 182: 498–504
90.
go back to reference Salzman C, Nobel K, Fisher J, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992; 7(7): 89–93 Salzman C, Nobel K, Fisher J, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992; 7(7): 89–93
91.
go back to reference Curran H, Collins R, Fletcher S, et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 2003; 33(7): 1223–37PubMed Curran H, Collins R, Fletcher S, et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 2003; 33(7): 1223–37PubMed
92.
go back to reference Lindsey PL. Psychotropic medication use among older adults: what all nurses need to know. J Gerontol Nurs 2009 Sep; 35(9): 28–38PubMedCentralPubMed Lindsey PL. Psychotropic medication use among older adults: what all nurses need to know. J Gerontol Nurs 2009 Sep; 35(9): 28–38PubMedCentralPubMed
93.
go back to reference Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian community care. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009 Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian community care. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009
94.
go back to reference Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian residential aged care facilities. Canberra (ACT): Australian ACSQHC, Commonwealth of Australia, 2009 Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian residential aged care facilities. Canberra (ACT): Australian ACSQHC, Commonwealth of Australia, 2009
95.
go back to reference Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian hospitals. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009 Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian hospitals. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009
96.
go back to reference National Collaborating Centre for Nursing and Supportive Care. Clinical practice guideline for the assessment and prevention of falls in older people: guidelines commissioned by the National Institute for Clinical Excellence (NICE) [clinical guideline 21]. London: Royal College of Nursing, 2004 National Collaborating Centre for Nursing and Supportive Care. Clinical practice guideline for the assessment and prevention of falls in older people: guidelines commissioned by the National Institute for Clinical Excellence (NICE) [clinical guideline 21]. London: Royal College of Nursing, 2004
97.
go back to reference Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011 Jan; 59(1): 148–57 Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011 Jan; 59(1): 148–57
98.
go back to reference Ballard C, Gauthier S, Cummings J, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009; 5(5): 245–55PubMed Ballard C, Gauthier S, Cummings J, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009; 5(5): 245–55PubMed
99.
go back to reference Hendriks G, Oude Voshaar R, Keijsers G, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 2008; 117(6): 403–11PubMed Hendriks G, Oude Voshaar R, Keijsers G, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 2008; 117(6): 403–11PubMed
100.
go back to reference Oude Voshaar R, Couvée J, van Balkom A, et al. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 2006; 189: 213–20 Oude Voshaar R, Couvée J, van Balkom A, et al. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 2006; 189: 213–20
102.
go back to reference Russell MA, Hill KD, Blackberry I, et al. The reliability and predictive accuracy of the falls risk for older people in the community assessment (FROP-Com) tool. Age Ageing 2008 Nov; 37(6): 634–9PubMed Russell MA, Hill KD, Blackberry I, et al. The reliability and predictive accuracy of the falls risk for older people in the community assessment (FROP-Com) tool. Age Ageing 2008 Nov; 37(6): 634–9PubMed
104.
go back to reference Lord SR, Menz HB, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003 Mar; 83(3): 237–52PubMed Lord SR, Menz HB, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003 Mar; 83(3): 237–52PubMed
105.
go back to reference Dollman WB, Leblanc VT, Stevens L, et al. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther 2005 Oct; 30(5): 425–32PubMed Dollman WB, Leblanc VT, Stevens L, et al. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther 2005 Oct; 30(5): 425–32PubMed
106.
go back to reference Dahl LJ, Wright R, Xiao A, et al. Quality improvement in long term care: the psychotropic assessment tool (PAT). J Am Med Dir Assoc 2008 Nov; 9(9): 676–83PubMedCentralPubMed Dahl LJ, Wright R, Xiao A, et al. Quality improvement in long term care: the psychotropic assessment tool (PAT). J Am Med Dir Assoc 2008 Nov; 9(9): 676–83PubMedCentralPubMed
107.
go back to reference Lampe L. Antidepressants: not just for depression. Aust Prescr 2005; 28(4): 91–3 Lampe L. Antidepressants: not just for depression. Aust Prescr 2005; 28(4): 91–3
108.
go back to reference Forsman AK, Schierenbeck I, Wahlbeck K. Psychosocial interventions for the prevention of depression in older adults: systematic review and meta-analysis. J Aging Health 2011; 23(3): 387–416PubMed Forsman AK, Schierenbeck I, Wahlbeck K. Psychosocial interventions for the prevention of depression in older adults: systematic review and meta-analysis. J Aging Health 2011; 23(3): 387–416PubMed
109.
go back to reference Krogh J, Nordentoft M, Sterne JA, et al. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 2011; 72(4): 529–38PubMed Krogh J, Nordentoft M, Sterne JA, et al. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 2011; 72(4): 529–38PubMed
110.
go back to reference Windle G, Hughes D, Linck P, et al. Is exercise effective in promoting mental well-being in older age? A systematic review. Aging Ment Health 2010 Aug; 14(6): 652–69PubMed Windle G, Hughes D, Linck P, et al. Is exercise effective in promoting mental well-being in older age? A systematic review. Aging Ment Health 2010 Aug; 14(6): 652–69PubMed
111.
go back to reference Smith AJ, Tett SE. An intervention to improve benzodiazepine use: anew approach. Fam Pract 2010 Jun; 27(3): 320–7PubMed Smith AJ, Tett SE. An intervention to improve benzodiazepine use: anew approach. Fam Pract 2010 Jun; 27(3): 320–7PubMed
112.
go back to reference Smith AJ, Tett SE. Interventions to improve benzodiazepine prescribing, lessons from the past 20 years to guide future interventions. BMC Health Serv Res 2010; 10(1): 321PubMedCentralPubMed Smith AJ, Tett SE. Interventions to improve benzodiazepine prescribing, lessons from the past 20 years to guide future interventions. BMC Health Serv Res 2010; 10(1): 321PubMedCentralPubMed
113.
go back to reference Cook JM, Marshall R, Masci C, et al. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 2007 Mar; 22(3): 303–7PubMedCentralPubMed Cook JM, Marshall R, Masci C, et al. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 2007 Mar; 22(3): 303–7PubMedCentralPubMed
Metadata
Title
Psychotropic Drug-Induced Falls in Older People
A Review of Interventions Aimed at Reducing the Problem
Authors
Professor Keith D. Hill
Rohan Wee
Publication date
01-01-2012
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 1/2012
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/11598420-000000000-00000

Other articles of this Issue 1/2012

Drugs & Aging 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.